News

February 22, 2021August 24, 2022

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

News

Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the U.K. for the treatment of adults with inoperable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based ... Read more

February 18, 2021February 18, 2021

Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

News

An open-label Phase 2 clinical trial will test the safety and efficacy of IRX-2, an experimental immunology-based cancer therapy, in combination with Keytruda (pembrolizumab) and chemotherapy. The study is enrolling ... Read more

February 15, 2021February 15, 2021

Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

News

Seagen’s Tukysa (tucatinib) has been approved by the European Commission (EC) as part of a triple-combination therapy for people with previously treated advanced or metastatic HER2-positive breast cancer. The EC approved ... Read more

February 11, 2021February 11, 2021

Trial Testing AL101 in TNBC Doses First Patient

News

The first participant has been dosed in the Phase 2 clinical trial TENACITY, which is evaluating Ayala Pharmaceuticals‘ investigational therapy AL101 as a treatment for Notch-activated recurrent or metastatic triple ... Read more

February 8, 2021February 8, 2021

‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer

News

After promising results from patients enrolled to date, Atossa Therapeutics halted an Australian Phase 2 clinical trial evaluating its investigative oral therapy Endoxifen in women newly diagnosed with invasive, estrogen ... Read more

February 4, 2021February 4, 2021

Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors

News

Theralink Technologies announced that it has begun testing its new profiling biomarker assay — a test that could potentially provide oncologists with key information about a patient’s specific tumor — ... Read more

February 1, 2021February 1, 2021

US Study Enrolling Women to Help Determine Best Screening Practices

News

A national study is seeking women in the U.S. to help determine the safest and best way to screen for breast cancer, and to improve on current guidelines. It’s being ... Read more

January 28, 2021January 28, 2021

Nonprofit Highlights Importance of Global Teamwork for World Cancer Day

News

In honor of World Cancer Day on Feb. 4, the Breast International Group (BIG) emphasized the importance of wide-scale cooperation in efforts to advance cancer research. “None of BIG’s achievements ... Read more

January 25, 2021January 25, 2021

Enhertu Approved in EU for Inoperable, Advanced Breast Cancer

News

The European Commission has conditionally approved Enhertu (trastuzumab deruxtecan) for adults in the EU with inoperable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens. ... Read more

January 21, 2021January 21, 2021

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

News

Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and Radiological Health, part of the U.S. Food and Drug Administration ... Read more